BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 48 filers reported holding BCLS ACQUISITION CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,448,000 | +1.2% | 843,122 | 0.0% | 3.64% | -21.8% |
Q2 2022 | $8,347,000 | +0.3% | 843,122 | 0.0% | 4.65% | +19.6% |
Q1 2022 | $8,322,000 | +0.7% | 843,122 | 0.0% | 3.89% | +11.9% |
Q4 2021 | $8,263,000 | -1.6% | 843,122 | 0.0% | 3.47% | +17.2% |
Q3 2021 | $8,397,000 | -5.4% | 843,122 | 0.0% | 2.96% | -16.5% |
Q2 2021 | $8,878,000 | -0.4% | 843,122 | 0.0% | 3.55% | +10.4% |
Q1 2021 | $8,912,000 | -5.0% | 843,122 | +0.1% | 3.21% | +25.8% |
Q4 2020 | $9,385,000 | – | 842,500 | – | 2.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,263,000 | 3.47% |
Finepoint Capital LP | 603,429 | $5,950,000 | 1.52% |
Samsara BioCapital, LLC | 300,000 | $2,940,000 | 0.57% |
COMMODORE CAPITAL LP | 250,000 | $2,450,000 | 0.57% |
Bain Capital Life Sciences Investors, LLC | 487,500 | $4,778,000 | 0.38% |
Asymmetry Capital Management, L.P. | 71,372 | $699,000 | 0.37% |
First Trust Capital Management L.P. | 206,257 | $2,021,000 | 0.35% |
Exos Asset Management LLC | 68,672 | $673,000 | 0.35% |
Altium Capital Management LP | 100,000 | $980,000 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 216,250 | $2,132,000 | 0.23% |